Graft vessel disease: the impact of immunosuppression and possible treatment strategies.
Meiser
B
B
Dept. of Cardiac Surgery, University of Munich, Grosshadern Medical Center, Germany.
Reichart
B
B
D000818:Animals; D003327:Coronary Disease / Q000209:etiology* / Q000473:pathology / Q000628:therapy*; D006084:Graft Rejection / Q000628:therapy*; D016027:Heart Transplantation / Q000473:pathology; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007371:Interferon-gamma / Q000008:administration & dosage; D008148:Lovastatin / Q000008:administration & dosage / Q000031:analogs & derivatives; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage; D010456:Peptides, Cyclic; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D019821:Simvastatin; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives
D007166:Immunosuppressive Agents; D009842:Oligopeptides; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D007371:Interferon-gamma; D008148:Lovastatin; D019821:Simvastatin